Biología de membranas y mecanismos de transducción de señales en farmacología aplicada.
BioFarma
Instituto de Investigación Sanitaria de Santiago de Compostela
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (7)
2024
-
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
Drug Delivery and Translational Research
2023
-
A continuous in silico learning strategy to identify safety liabilities in compounds used in the leather and textile industry
Archives of Toxicology, Vol. 97, Núm. 4, pp. 1091-1111
-
Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia
Molecules, Vol. 28, Núm. 10
-
Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling
European Journal of Medicinal Chemistry, Vol. 252
-
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation
Journal of enzyme inhibition and medicinal chemistry, Vol. 38, Núm. 1, pp. 2209828
-
Secretome Profile of Leukocyte-Platelet-Rich Fibrin (L-PRF) Membranes
Methods in molecular biology (Clifton, N.J.), Vol. 2628, pp. 207-219
2022
-
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1